LOGIN

International Epidemiology Databases to Evaluate AIDS

Home >> Publications >> First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Nepal.

Publication

Author(s):

Malla B, Stucki D, Borrell S, Feldmann J, Maharjan B, Shrestha B, Fenner L, Gagneux S.

Pub Title:

First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Nepal.

Pub Date:

Dec 31 2012

Pub Region(s):

Southern Africa

Journal Issue:

12

Page Number:
e52297

Journal:

Title: 
PLoS One
Link: 
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0052297

PubMed: 23300635
Pub PDF: PDF icon 23300635.pdf

Abstract
BACKGROUND
: Tuberculosis (TB) is a major public health problem in Nepal. Strain variation in Mycobacterium tuberculosis may influence the outcome of TB infection and disease. To date, the phylogenetic diversity of M. tuberculosis in Nepal is unknown.

METHODS AND FINDINGS: We analyzed 261 M. tuberculosis isolates recovered from pulmonary TB patients recruited between August 2009 and August 2010 in Nepal. M. tuberculosis lineages were determined by single nucleotide polymorphisms (SNP) typing and spoligotyping. Drug resistance was determined by sequencing the hot spot regions of the relevant target genes. Overall, 164 (62.8%) TB patients were new, and 97 (37.2%) were previously treated. Any drug resistance was detected in 50 (19.2%) isolates, and 16 (6.1%) were multidrug-resistant. The most frequent M. tuberculosis lineage was Lineage 3 (CAS/Delhi) with 106 isolates (40.6%), followed by Lineage 2 (East-Asian lineage, includes Beijing genotype) with 84 isolates (32.2%), Lineage 4 (Euro-American lineage) with 41 (15.7%) isolates, and Lineage 1 (Indo-Oceanic lineage) with 30 isolates (11.5%). Based on spoligotyping, we found 45 different spoligotyping patterns that were previously described. The Beijing (83 isolates, 31.8%) and CAS spoligotype (52, 19.9%) were the dominant spoligotypes. A total of 36 (13.8%) isolates could not be assigned to any known spoligotyping pattern. Lineage 2 was associated with female sex (adjusted odds ratio [aOR] 2.58, 95% confidence interval [95% CI] 1.42-4.67, p = 0.002), and any drug resistance (aOR 2.79; 95% CI 1.43-5.45; p = 0.002). We found no evidence for an association of Lineage 2 with age or BCG vaccination status.

CONCLUSIONS: We found a large genetic diversity of M. tuberculosis in Nepal with representation of all four major lineages. Lineages 3 and 2 were dominating. Lineage 2 was associated with clinical characteristics. This study fills an important gap on the map of the M. tuberculosis genetic diversity in the Asian region.

PMID: 23300635 [PubMed - indexed for MEDLINE]

PMCID: PMC3530561

 

The following websites provide guidelines and policies when citing from PubMed®: http://www.ncbi.nlm.nih.gov/books/NBK7243/
http://www.nlm.nih.gov/bsd/policy/cit_format.html

Citation:

Malla B, Stucki D, Borrell S, Feldmann J, Maharjan B, Shrestha B, Fenner L, Gagneux S. First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Nepal. PLoS One. 2012;7(12):e52297. doi: 10.1371/journal.pone.0052297. Epub 2012 Dec 26. PubMed PMID: 23300635; PubMed Central PMCID: PMC3530561.